About Lotus Tissue Repair
Lotus Tissue Repair is a company based in Cambridge (United States) founded in 2010 by Mei Chen was acquired by Shire in January 2013.. Lotus Tissue Repair has raised $26 million across 1 funding round from investors including Takeda Pharmaceuticals and Third Rock Ventures. Lotus Tissue Repair operates in a competitive market with competitors including QBiotics, MediWound, Collplant, Ilya Pharma and Resolution Therapeutics, among others.
- Headquarter Cambridge, United States
- Founders Mei Chen
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lotus Tissue Repair Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26 M (USD)
in 1 rounds
-
Latest Funding Round
$26 M (USD), Series A
Jun 30, 2011
-
Investors
Takeda Pharmaceuticals
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Shire
(Jan 08, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lotus Tissue Repair
Lotus Tissue Repair has successfully raised a total of $26M through 1 strategic funding round. The most recent funding activity was a Series A round of $26 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $26.0M
-
First Round
First Round
(30 Jun 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2011 | Amount | Series A - Lotus Tissue Repair | Valuation | Third Rock Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lotus Tissue Repair
Lotus Tissue Repair has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals and Third Rock Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location | |
|
Rare disease treatments are developed by a specialty biopharmaceutical firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lotus Tissue Repair
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lotus Tissue Repair
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lotus Tissue Repair Comparisons
Competitors of Lotus Tissue Repair
Lotus Tissue Repair operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Collplant, Ilya Pharma and Resolution Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| domain | founded_year | HQ Location |
Powdered fibrin sealant for surgical bleeding
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lotus Tissue Repair
Frequently Asked Questions about Lotus Tissue Repair
When was Lotus Tissue Repair founded?
Lotus Tissue Repair was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Lotus Tissue Repair located?
Lotus Tissue Repair is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Lotus Tissue Repair a funded company?
Lotus Tissue Repair is a funded company, having raised a total of $26M across 1 funding round to date. The company's 1st funding round was a Series A of $26M, raised on Jun 30, 2011.
What does Lotus Tissue Repair do?
Lotus Tissue Repair develops recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company offers its rC7 technology for chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers, and similar conditions. As of February 12, 2013, Lotus Tissue Repair, Inc. operates as a subsidiary of Shire plc.
Who are the top competitors of Lotus Tissue Repair?
Lotus Tissue Repair's top competitors include Ilya Pharma, Collplant and QBiotics.
Who are Lotus Tissue Repair's investors?
Lotus Tissue Repair has 2 investors. Key investors include Takeda Pharmaceuticals, and Third Rock Ventures.